323 related articles for article (PubMed ID: 32612989)
1. Plasma Metabolic Profiling of Human Thyroid Nodules by Gas Chromatography-Mass Spectrometry (GC-MS)-Based Untargeted Metabolomics.
Abooshahab R; Hooshmand K; Razavi SA; Gholami M; Sanoie M; Hedayati M
Front Cell Dev Biol; 2020; 8():385. PubMed ID: 32612989
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
3. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW
Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614
[TBL] [Abstract][Full Text] [Related]
4. Plasma metabolites analysis of patients with papillary thyroid cancer: A preliminary untargeted
Razavi SA; Mahmanzar M; Nobakht M Gh BF; Zamani Z; Nasiri S; Hedayati M
J Pharm Biomed Anal; 2024 Apr; 241():115946. PubMed ID: 38241910
[TBL] [Abstract][Full Text] [Related]
5. Gas chromatography-mass spectrometry-based untargeted metabolomics reveals metabolic perturbations in medullary thyroid carcinoma.
Jajin MG; Abooshahab R; Hooshmand K; Moradi A; Siadat SD; Mirzazadeh R; Chegini KG; Hedayati M
Sci Rep; 2022 May; 12(1):8397. PubMed ID: 35590091
[TBL] [Abstract][Full Text] [Related]
6. Serum Metabolomics Study of Papillary Thyroid Carcinoma Based on HPLC-Q-TOF-MS/MS.
Du Y; Fan P; Zou L; Jiang Y; Gu X; Yu J; Zhang C
Front Cell Dev Biol; 2021; 9():593510. PubMed ID: 33598460
[TBL] [Abstract][Full Text] [Related]
7. GC-MS metabolomics identifies novel biomarkers to distinguish tuberculosis pleural effusion from malignant pleural effusion.
Liu Y; Mei B; Chen D; Cai L
J Clin Lab Anal; 2021 Apr; 35(4):e23706. PubMed ID: 33528039
[TBL] [Abstract][Full Text] [Related]
8. Metabolic changes associated with papillary thyroid carcinoma: A nuclear magnetic resonance-based metabolomics study.
Li Y; Chen M; Liu C; Xia Y; Xu B; Hu Y; Chen T; Shen M; Tang W
Int J Mol Med; 2018 May; 41(5):3006-3014. PubMed ID: 29484373
[TBL] [Abstract][Full Text] [Related]
9. A distinct serum metabolic signature of distant metastatic papillary thyroid carcinoma.
Shen CT; Zhang Y; Liu YM; Yin S; Zhang XY; Wei WJ; Sun ZK; Song HJ; Qiu ZL; Wang CR; Luo QY
Clin Endocrinol (Oxf); 2017 Dec; 87(6):844-852. PubMed ID: 28755525
[TBL] [Abstract][Full Text] [Related]
10. Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter.
Yao Z; Yin P; Su D; Peng Z; Zhou L; Ma L; Guo W; Ma L; Xu G; Shi J; Jiao B
Mol Biosyst; 2011 Sep; 7(9):2608-14. PubMed ID: 21713270
[TBL] [Abstract][Full Text] [Related]
11. Integrative metabolomic characterization identifies plasma metabolomic signature in the diagnosis of papillary thyroid cancer.
Yu S; Liu C; Hou Y; Li J; Guo Z; Chen X; Zhang L; Peng S; Hong S; Xu L; Li X; Liu R; Chen S; Li B; Weng Z; Li Y; Lv W; Yu J; Xiao H
Oncogene; 2022 Apr; 41(17):2422-2430. PubMed ID: 35279704
[TBL] [Abstract][Full Text] [Related]
12. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics for Age Discrimination of Ginseng Using a Multiplex Approach to HR-MAS NMR Spectroscopy, UPLC-QTOF/MS, and GC × GC-TOF/MS.
Yoon D; Choi BR; Ma S; Lee JW; Jo IH; Lee YS; Kim GS; Kim S; Lee DY
Molecules; 2019 Jun; 24(13):. PubMed ID: 31252608
[TBL] [Abstract][Full Text] [Related]
14. Urinary Metabolomics Study of Patients with Gout Using Gas Chromatography-Mass Spectrometry.
Li Q; Wei S; Wu D; Wen C; Zhou J
Biomed Res Int; 2018; 2018():3461572. PubMed ID: 30410926
[TBL] [Abstract][Full Text] [Related]
15. The Use of Gas Chromatography Coupled with High-Resolution Mass Spectrometry-Based Untargeted Metabolomics to Discover Metabolic Changes and Help in the Determination of Complex Causes of Death: A Preliminary Study.
Zhang K; Yan H; Liu R; Xiang P; Zhang J; Deng K; Huang P; Wang Z
ACS Omega; 2021 Jan; 6(3):2100-2109. PubMed ID: 33521449
[TBL] [Abstract][Full Text] [Related]
16. Distinct Metabolomic Profiles of Papillary Thyroid Carcinoma and Benign Thyroid Adenoma.
Xu Y; Zheng X; Qiu Y; Jia W; Wang J; Yin S
J Proteome Res; 2015 Aug; 14(8):3315-21. PubMed ID: 26130307
[TBL] [Abstract][Full Text] [Related]
17. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
18. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
[TBL] [Abstract][Full Text] [Related]
19. GC-MS-based metabolomic analysis of human papillary thyroid carcinoma tissue.
Chen M; Shen M; Li Y; Liu C; Zhou K; Hu W; Xu B; Xia Y; Tang W
Int J Mol Med; 2015 Dec; 36(6):1607-14. PubMed ID: 26459747
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
